VolitionRX Ltd logo

VolitionRX Ltd

$ 1.46 +0.07 (+5.04%) 04:00 PM EST
P/E:
At Loss
P/B:
17.59
Market Cap:
$ 83.66M
Enterprise V:
$ 66.99M
Volume:
49.28K
Avg Vol (2M):
121.87K
Volume:
49.28K
Market Cap $:
83.66M
PE Ratio:
At Loss
Avg Vol (2-Month):
121.87K
Enterprise Value $:
66.99M
PB Ratio:
17.59
GF Score:
Year:
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
VolitionRX Ltd is a us-based multi-national life sciences company. It is engaged in developing easy to use blood-based tests to accurately diagnose a range of cancers. The development pipeline includes assays to be used for symptomatic patients or asymptomatic populations. The company has developed more than 30 blood-based assays to detect specific biomarkers. It also develops Nucleosomics tests for several major cancers including CRC, pancreatic, lung and aggressive prostate. In addition, the company engages in the process of developing HyperGenomics tissue and blood-based tests to determine disease subtype following initial diagnosis and to help decide the appropriate therapy.
Name Current Vs Industry Vs History
Cash-To-Debt 4.1
Equity-to-Asset 0.18
Debt-to-Equity 0.91
Debt-to-EBITDA -0.14
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -10.47
Distress
Grey
Safe
Beneish M-Score -5.5
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 25.39
9-Day RSI 27.46
14-Day RSI 30.81
6-1 Month Momentum % -45.9
12-1 Month Momentum % -45.36

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 1.07
Quick Ratio 1.07
Cash Ratio 0.96
Days Sales Outstanding 48.79

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -15
Name Current Vs Industry Vs History
Operating Margin % -15854.4
Net Margin % -15779.79
ROE % -186.63
ROA % -102.36
ROIC % -281.43
ROC (Joel Greenblatt) % -559.75
ROCE % -159.08

Financials (Next Earnings Date:2022-11-11 Est.)

VNRX's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with AMEX:VNRX

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Valuation Box

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.193
EPS (TTM) ($) -0.56
Beta 1.13
Volatility % 35.93
14-Day RSI 30.81
14-Day ATR ($) 0.097439
20-Day SMA ($) 1.6175
12-1 Month Momentum % -45.36
52-Week Range ($) 1.31 - 4.1401
Shares Outstanding (Mil) 57.3

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

VolitionRX Ltd Filings

Document Form Filing Date
No Filing Data

VolitionRX Ltd Analysis

Share your research

Headlines

See More
No news.